+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antibody Fragments Market by Product Type, Application, End User, Technology, Distribution Channel - Global Forecast to 2030- Product Image
Antibody Fragments Market by Product Type, Application, End User, Technology, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Antibody Fragments Market by Product Type, Application, End User, Technology, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5665739
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior leaders navigating the complex biotechnology landscape are turning to antibody fragments to unlock new efficiencies and growth in diagnostics and therapeutics. An evolving ecosystem, fueled by innovation and changing policy, is reshaping molecular targeting strategies for organizations seeking a competitive edge.

Market Snapshot: Antibody Fragments Market Growth and Dynamics

The antibody fragments market expanded from USD 8.07 billion in 2024 to USD 8.43 billion in 2025, advancing at a compound annual growth rate (CAGR) of 4.35%. Projections indicate the sector will reach USD 10.42 billion by 2030, driven by the widespread adoption of advanced diagnostic and therapeutic platforms. Robust demand stems from increased focus on precision medicine, innovations in protein engineering, and the need for modifiable molecular targeting approaches across global markets.

Scope & Segmentation

This report provides a comprehensive view of the antibody fragments market by analyzing diverse product formats, expanding applications, end-user environments, enabling technologies, distribution channels, and key geographies.

  • Product Types: Diabodies (camelid and shark derivatives), Fab fragments (chimeric, fully human, humanized, murine), Fab'2 fragments (chimeric, fully human, humanized, murine), nanobodies (camelid, shark), and single chain variable fragments (chimeric, fully human, humanized, murine).
  • Applications: Diagnostics (imaging, in vitro diagnostics, point of care testing), drug delivery (gene and targeted drug delivery), research (basic, drug discovery, preclinical), and therapeutics (infectious, inflammatory, oncology uses).
  • End Users: Academic and research institutes, contract research organizations, diagnostic laboratories, pharmaceutical and biotechnology companies.
  • Technologies: Hybridoma, molecular cloning, phage display (filamentous, lambda, T7), and recombinant technology (bacterial, mammalian, yeast expression systems).
  • Distribution Channels: Direct sales, distributors, online sales (company websites, third-party e-commerce).
  • Geographies: Americas (including United States, Canada, key Latin American markets), EMEA (United Kingdom, Germany, France, major Middle Eastern and African nations), and Asia-Pacific regions (China, India, Japan, Southeast Asia, Australia).
  • Leading Companies: Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Bio-Rad Laboratories, Inc., PerkinElmer, Inc., QIAGEN N.V., Abcam plc, GenScript Biotech Corporation, Sanofi S.A., and MorphoSys AG.

Key Takeaways: Strategy Insights for Decision-Makers

  • Antibody fragments have become essential for organizations prioritizing rapid, precise molecular targeting in diagnostics and therapeutics. Their novel formats offer enhanced tissue penetration, optimized pharmacokinetics, and flexible engineering possibilities.
  • Strong industry momentum is rooted in the adoption of recombinant expression, advanced binding site optimization, and AI-driven high-throughput platforms, transforming the pace of drug discovery and clinical transition.
  • Regional diversity drives market expansion; advanced research networks and government incentives foster adoption in North America, Europe, and Asia-Pacific, while emerging markets strengthen their capacity through local production initiatives.
  • Collaboration between industry leaders, academia, and contract research organizations underpins innovation, enabling faster market introduction of new fragment-based solutions and establishing robust supply chains.
  • As customization takes precedence, aligning product offerings with specific end-user preferences and regulatory settings provides measurable differentiation and sustained demand.

Tariff Impact: Adjusting the Global Supply Chain

The introduction of cumulative tariffs on imported raw materials and reagents in 2025 has significantly altered supply chain strategies across the antibody fragment market. Companies face increased manufacturing costs due to higher duties on key components. Organizations are responding by localizing production, renegotiating sourcing contracts, and exploring bulk procurement strategies to maintain margin stability and operational efficiency. These tariff-induced adjustments underscore the importance of regional risk management and supply chain resilience for all stakeholders.

Methodology & Data Sources

This report combines comprehensive secondary analysis of scientific literature and industry sources with primary insights from interviews with executives and technical experts. Data triangulation across commercial and proprietary datasets ensures accurate, scenario-based market forecasts. Quality assurance includes iterative peer reviews by subject matter specialists to validate findings and maintain rigor.

Why This Report Matters

  • Enables executives to confidently refine investment priorities and optimize global product portfolios aligned with evolving market signals.
  • Delivers actionable insights on technology trends, supply dynamics, and regional priorities directly relevant to business planning and risk mitigation.
  • Supports cross-functional teams in identifying growth opportunities and crafting strategies calibrated for precision medicine’s future demands.

Conclusion

The antibody fragments market stands at a transformational juncture, defined by innovation, new regulatory requirements, and shifting global dynamics. Senior leaders leveraging these insights will maintain a competitive edge and drive future biotechnology success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antibody Fragments Market, by Product Type
8.1. Introduction
8.2. Diabodies
8.2.1. Camelid
8.2.2. Shark
8.3. Fab Fragments
8.3.1. Chimeric
8.3.2. Fully Human
8.3.3. Humanized
8.3.4. Murine
8.4. Fab'2 Fragments
8.4.1. Chimeric
8.4.2. Fully Human
8.4.3. Humanized
8.4.4. Murine
8.5. Nanobodies
8.5.1. Camelid
8.5.2. Shark
8.6. Single Chain Variable Fragments
8.6.1. Chimeric
8.6.2. Fully Human
8.6.3. Humanized
8.6.4. Murine
9. Antibody Fragments Market, by Application
9.1. Introduction
9.2. Diagnostics
9.2.1. Imaging
9.2.2. In Vitro Diagnostics
9.2.3. Point Of Care Testing
9.3. Drug Delivery
9.3.1. Gene Delivery
9.3.2. Targeted Drug Delivery
9.4. Research
9.4.1. Basic Research
9.4.2. Drug Discovery
9.4.3. Preclinical Research
9.5. Therapeutics
9.5.1. Infectious Diseases
9.5.2. Inflammatory Diseases
9.5.3. Oncology
10. Antibody Fragments Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Contract Research Organizations
10.4. Diagnostic Laboratories
10.5. Pharmaceutical And Biotechnology Companies
11. Antibody Fragments Market, by Technology
11.1. Introduction
11.2. Hybridoma
11.3. Molecular Cloning
11.4. Phage Display
11.4.1. Filamentous Phage
11.4.2. Lambda Phage
11.4.3. T7 Phage
11.5. Recombinant Technology
11.5.1. Bacterial Expression
11.5.2. Mammalian Expression
11.5.3. Yeast Expression
12. Antibody Fragments Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online Sales
12.4.1. Company Website
12.4.2. Third Party E-Commerce
13. Americas Antibody Fragments Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antibody Fragments Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antibody Fragments Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Danaher Corporation
16.3.3. Merck KGaA
16.3.4. Bio-Rad Laboratories, Inc.
16.3.5. PerkinElmer, Inc.
16.3.6. QIAGEN N.V.
16.3.7. Abcam plc
16.3.8. GenScript Biotech Corporation
16.3.9. Sanofi S.A.
16.3.10. MorphoSys AG
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIBODY FRAGMENTS MARKET MULTI-CURRENCY
FIGURE 2. ANTIBODY FRAGMENTS MARKET MULTI-LANGUAGE
FIGURE 3. ANTIBODY FRAGMENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTIBODY FRAGMENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTIBODY FRAGMENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTIBODY FRAGMENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CAMELID, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SHARK, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CAMELID, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SHARK, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CHIMERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FULLY HUMAN, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HUMANIZED, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MURINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY IN VITRO DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY GENE DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TARGETED DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PRECLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY HYBRIDOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MOLECULAR CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY FILAMENTOUS PHAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY LAMBDA PHAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY T7 PHAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY BACTERIAL EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY MAMMALIAN EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY YEAST EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY COMPANY WEBSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY THIRD PARTY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES ANTIBODY FRAGMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 114. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 116. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 117. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 118. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 119. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 120. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 122. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 123. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 124. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 125. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 128. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. CANADA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 131. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 135. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 137. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 139. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 140. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 141. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 143. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 145. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. MEXICO ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 217. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 218. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 219. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 222. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 223. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 224. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 225. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 226. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 227. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 228. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 231. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 232. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. GERMANY ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 234. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 235. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 236. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 237. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 239. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 240. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 241. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 242. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 244. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 245. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 247. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 248. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. FRANCE ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 268. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 270. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 271. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 272. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 273. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 274. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 275. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 276. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 277. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 278. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 279. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 281. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 282. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. ITALY ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 285. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 286. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 287. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 291. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 294. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 295. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 296. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 297. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 299. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. SPAIN ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB'2 FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY NANOBODIES, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY SINGLE CHAIN VARIABLE FRAGMENTS, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY DRUG DELIVERY, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY RESEARCH, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY THERAPEUTICS, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 332. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY PHAGE DISPLAY, 2018-2030 (USD MILLION)
TABLE 333. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY RECOMBINANT TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 334. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. SAUDI ARABIA ANTIBODY FRAGMENTS MARKET SIZE, BY ONLINE SALES, 2018-2030 (USD MILLION)
TABLE 336. SOUTH AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 337. SOUTH AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY DIABODIES, 2018-2030 (USD MILLION)
TABLE 338. SOUTH AFRICA ANTIBODY FRAGMENTS MARKET SIZE, BY FAB FRAGMENTS, 2018-2030 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antibody Fragments market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • PerkinElmer, Inc.
  • QIAGEN N.V.
  • Abcam plc
  • GenScript Biotech Corporation
  • Sanofi S.A.
  • MorphoSys AG

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 8.43 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.42 Billion
Compound Annual Growth Rate4.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Antibody Fragments - Global Strategic Business Report - Product Image

Antibody Fragments - Global Strategic Business Report

  • Report
  • 176 Pages
  • Global
From
Monoclonal Antibodies Market by Application, Product Type, Technology, Source, End User - Global Forecast to 2030 - Product Image

Monoclonal Antibodies Market by Application, Product Type, Technology, Source, End User - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Custom Antibody Development & Production Service Market by Service Type, Antibody Type, Application, Technology, End User - Global Forecast to 2030 - Product Image

Custom Antibody Development & Production Service Market by Service Type, Antibody Type, Application, Technology, End User - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Engineered Antibody Therapeutics for Cancer - Product Image

Engineered Antibody Therapeutics for Cancer

  • Report
  • Global
From
Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Monoclonal Antibody Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From

About the Antibody Fragment Market

The Antibody Fragment market within the context of Oncology Drugs is a rapidly growing field of biotechnology. Antibody Fragments are small pieces of antibodies that are used to target and treat cancer cells. They are designed to bind to specific antigens on the surface of cancer cells, allowing them to be targeted and destroyed. Antibody Fragments are also used to deliver drugs directly to cancer cells, increasing the effectiveness of the drug. This technology has been used to develop a variety of cancer treatments, including monoclonal antibodies, bispecific antibodies, and antibody-drug conjugates. The Antibody Fragment market is expected to continue to grow as new treatments are developed and approved. This growth is driven by the increasing prevalence of cancer, as well as the need for more effective treatments. Some companies in the Antibody Fragment market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.